Rashmi Ramasubbaiah MD MS
Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Medical Director, Hematology oncology, Marshall medical center
Join to View Full Profile
3581 Palmer Drive suite 400Cameron Park, CA 95682
Phone+1 530-676-6600
Fax+1 530-676-6673
Dr. Ramasubbaiah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rashmi Ramasubbaiah is an oncologist in Cameron Park, CA and is affiliated with Marshall Medical Center. She received her medical degree from Sri Devaraj URS Medical College and has been in practice 18 years. She specializes in breast cancer, gastrointestinal cancer, and hematologic oncology.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2010
Carle Foundation HospitalResidency, Internal Medicine, 2004 - 2007- Western Kentucky UniversityMS, Biology, microbiology, inmunology, Ooutstanding graduate student, 2001 - 2004
Sri Devaraj URS Medical CollegeClass of 1999
Certifications & Licensure
CA State Medical License 2013 - 2026
MO State Medical License 2010 - 2014
IL State Medical License 2007 - 2007
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Publications & Presentations
PubMed
- 69 citationsMiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.John K. Chan, Tuyen K. Kiet, Kevin Blansit, Rashmi Ramasubbaiah, Joan F. Hilton
Gynecologic Oncology. 2014-06-01 - 59 citationsPhase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101E. Gabriela Chiorean, Rashmi Ramasubbaiah, Menggang Yu, Joel Picus, Jose A. Bufill
The Oncologist. 2012-01-01 - 44 citationsSorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology GroupR. Ramasubbaiah, Susan M. Perkins, Jeanne M. Schilder, C. Whalen, Cynthia S. Johnson
Gynecologic Oncology. 2011-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
